This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
Teradyne (TER) Q2 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Teradyne's (TER) second-quarter 2021 results reflect strength across test and IA businesses.
Maxim (MXIM) Earnings & Revenues Surpass Estimates in Q4
by Zacks Equity Research
Maxim (MXIM) fiscal fourth-quarter results reflect strong momentum across automotive, industrial and consumer markets.
Nielsen (NLSN) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Nielsen Holdings' (NLSN) second-quarter 2021 results are likely to reflect strength across Audience Measurement, Audience Outcomes and Gracenote Content Services.
Carrier (CARR) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Carrier Global's (CARR) second-quarter 2021 results are expected to reflect benefits from solid demand for residential HVAC, and growing momentum across aftermarket as well as digital offerings.
KLA Corp. (KLAC) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
KLA Corp.'s (KLAC) fiscal fourth-quarter 2021 results are likely to reflect strength across semiconductor process control systems and services.
Fortive (FTV) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Fortive's (FTV) second-quarter 2021 results are likely to reflect strength across software and healthcare portfolios.
Agilent (A) Expands pharmDX Assay Use in the European Union
by Zacks Equity Research
Agilent Technologies (A) expands the use of PD-L1 IHC 22C3 pharmDx assay for cancer treatment in the European Union.
Looking for Computer and Technology Stocks? The Zacks Rank Can Help You Find Winners
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
GoDaddy (GDDY) & Google Unite to Empower Small Businesses
by Zacks Equity Research
GoDaddy (GDDY) joins forces with Google to help small businesses reach millions of customers.
5 Top-Ranked Stocks That Have Emerged as DuPont Winners
by Sanghamitra Saha
Use the DuPont technique to pick solid profit-generating stocks like A, CHRW, BLDR, LSTR and MED.
GoDaddy (GDDY) Unveils List for Sale, Bolsters Domain Portfolio
by Zacks Equity Research
GoDaddy (GDDY) introduces List for Sale to help customers with seamless listing and sell unused domain names.
What Makes Agilent Technologies (A) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out.
Agilent Technologies (A) Boasts Earnings & Price Momentum: Should You Buy?
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
How to Find Strong Buy Computer and Technology Stocks Using the Zacks Rank
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Agilent (A) Up 10.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Agilent (A) Expands Presence in LC Market With New Systems
by Zacks Equity Research
Agilent (A) expands its Bio Liquid Chromatography solutions portfolio with three new systems to fulfil the needs of biopharma industry.
Adobe (ADBE) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Adobe's fiscal second-quarter results benefit from the solid performance of Creative Cloud, Document Cloud and Experience Cloud.
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Is Agilent Technologies (A) Stock Outpacing Its Computer and Technology Peers This Year?
by Zacks Equity Research
Is (A) Outperforming Other Computer and Technology Stocks This Year?
Surging Earnings Estimates Signal Upside for Agilent (A) Stock
by Zacks Equity Research
Agilent (A) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Are You Looking for a Top Momentum Pick? Why Agilent Technologies (A) is a Great Choice
by Zacks Equity Research
Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out.
Agilent (A) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Agilent's (A) fiscal second-quarter results benefit from strength across all geographical regions and end-market momentum.
Agilent Technologies (A) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 18.29% and 9.91%, respectively, for the quarter ended April 2021. Do the numbers hold clues to what lies ahead for the stock?
Agilent (A) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Agilent's (A) fiscal second-quarter results are expected to reflect portfolio strength and end-market momentum.
Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.